Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) United States Patent (10) Patent No.: US 9,526,728 B2 Klein Et Al
- Aldose Reductase Inhibitors As Potential Therapeutic Drugs of Diabetic Complications
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- (12) United States Patent (10) Patent No.: US 9,006.403 B2 Liou Et Al
- Diabetic Neuropathy: Cellular Mechanisms As Therapeutic Targets Andrea M
- Pharmaabkommen A1 E
- Exercise and Type 1 Diabetes (T1DM) Pietro Galassetti*1 and Michael C
- (12) United States Patent (10) Patent No.: US 6,337,327 B1 Tuffin Et Al
- (12) Patent Application Publication (10) Pub. No.: US 2017/0014495 A1 Sarangarajan Et Al
- (12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) Rats: a Role of Aldose Reductase
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Grapefruit Juice Ameliorates Nephropathy in Streptozotocin Induced Diabetes
- (12) Patent Application Publication (10) Pub. No.: US 2014/0296257 A1 Hersel Et Al
- Intranasal Insulin for Treatment of Diabetic Polyneuropathy
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-Diabetic Diseases
- Improvement of Motor Nerve Conduction Velocity in Diabetic Rats Requires Normalization of the Polyol Pathway Metabolites Flux
- WO 2011/012715 Al
- WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
- Effects of a Novel Potent Aldose Reductase Inhibitor, GP-1447, on Aldose Reductase Activity in Vitro and on Diabetic Neuropathy and Cataract Formation in Rats
- Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications Irina G